NATIXIS recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Natixis is an investment banking corporation based out of France. The company can trace its history back to 1818 when the Caisse d’Epargne bank was created in Paris. The bank would grow and reach 364 total banks in 1847. Natixis can also trace its history back to the creation of the Banque Populaire bank in 1878 in Angers, Crédit National in 1919, Caisse Centrale des Banques Populaires in 1921, and Banque Française du Commerce Extérieur. Natexis S.A. would be created out of the merger between Crédit National and Banque Française du Commerce Extérieur in 1996. The company would then be bought by the Caisse Centrale des Banques Populaires or CCBP, becoming Groupe Banque Populaire’s listed vehicle. Natexis S.A. would become Natexis Banques Populaires under CCBP in 1999. In the same year, the Caisse Nationale des Caisses d’Epargne would be created, which would acquire the spinoff company of Caisse des Dépôts, CDC IXIS, which handled its non-public service financial activities in 2004. In 2006, IXIS’s activities would become merged with Natexis Banques Populaires to create the current Natixis. Natixis currently operates as a subsidiary of Groupe BPCE, which was created out of the merger between Caisse Nationale des Caisses d’Epargne and Banque Fédérale des Banques Populaires and is currently the second largest banking group in France. The company currently has more than 20,000 employees with over a third of them working abroad. Natixis holds over $650 billion in total assets and brings in over $1.4 billion in net income. The company operates through its major sectors, mainly through held subsidiaries, which includes Corporate & Investment Banking, Asset Management – mainly through Natixis Global Asset Management, which is currently the 14th largest asset management firm in the world, Private Equity & Private Banking, Services, and Receivables Management. Natixis invests most heavily in the finance sector, which alone makes up over 40% of its total asset allocations.
As of the latest 13F report, the guru’s equity portfolio contained 1145 stocks valued at a total of $27.59Bil. The top holdings were TSLA(37.75%), AAPL(3.50%), and AMZN(2.31%).
According to GuruFocus data, these were NATIXIS’s top five trades of the quarter.
Tesla Inc
During the quarter, NATIXIS bought 14,777,045 shares of NAS:TSLA for a total holding of 15,271,638. The trade had a 36.53% impact on the equity portfolio. During the quarter, the stock traded for an average price of $822.98.
On 08/14/2022, Tesla Inc traded for a price of $900.09 per share and a market cap of $940.14Bil. The stock has returned 24.62% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, Tesla Inc has a price-earnings ratio of 108.44, a price-book ratio of 25.76, a EV-to-Ebitda ratio of 64.75 and a price-sales ratio of 15.29.
The price-to-GF Value ratio is 0.88, earning the stock a GF Value rank of 7.
S&P 500 ETF TRUST ETF
The guru sold out of their 5,837,077-share investment in ARCA:SPY. Previously, the stock had a 9.2% weight in the equity portfolio. Shares traded for an average price of $408.8 during the quarter.
On 08/14/2022, S&P 500 ETF TRUST ETF traded for a price of $427.1 per share and a market cap of $392.88Bil. The stock has returned -2.68% over the past year.
GuruFocus gives the ETF a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, S&P 500 ETF TRUST ETF has a price-earnings ratio of 20.20, a price-book ratio of 3.85, a price-earnings-to-growth (PEG) ratio of 2.43, a EV-to-Ebitda ratio of 15.19 and a price-sales ratio of 3.01.
The price-to-GF Value ratio is 0.00, earning the stock a GF Value rank of 6.
PowerShares QQQ Trust Ser 1
The guru sold out of their 2,150,000-share investment in NAS:QQQ. Previously, the stock had a 2.71% weight in the equity portfolio. Shares traded for an average price of $310.63 during the quarter.
On 08/14/2022, PowerShares QQQ Trust Ser 1 traded for a price of $330.39 per share and a market cap of $182.62Bil. The stock has returned -9.61% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, PowerShares QQQ Trust Ser 1 has a price-earnings ratio of 25.00 and a price-book ratio of 6.60.
Alibaba Group Holding Ltd
NATIXIS reduced their investment in NYSE:BABA by 3,960,901 shares. The trade had a 1.5% impact on the equity portfolio. During the quarter, the stock traded for an average price of $98.24.
On 08/14/2022, Alibaba Group Holding Ltd traded for a price of $94.77 per share and a market cap of $250.91Bil. The stock has returned -50.55% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Alibaba Group Holding Ltd has a price-earnings ratio of 52.65, a price-book ratio of 1.74, a price-earnings-to-growth (PEG) ratio of 3.87, a EV-to-Ebitda ratio of 15.45 and a price-sales ratio of 1.94.
The price-to-GF Value ratio is 0.26, earning the stock a GF Value rank of 2.
Bristol-Myers Squibb Co
During the quarter, NATIXIS bought 4,885,184 shares of NYSE:BMY for a total holding of 5,677,980. The trade had a 1.36% impact on the equity portfolio. During the quarter, the stock traded for an average price of $76.11.
On 08/14/2022, Bristol-Myers Squibb Co traded for a price of $75.57 per share and a market cap of $161.36Bil. The stock has returned 16.03% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Bristol-Myers Squibb Co has a price-earnings ratio of 25.11, a price-book ratio of 4.95, a price-earnings-to-growth (PEG) ratio of 3.14, a EV-to-Ebitda ratio of 9.84 and a price-sales ratio of 3.52.
The price-to-GF Value ratio is 1.00, earning the stock a GF Value rank of 6.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
